Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: J Perinatol. 2022 Aug 27;43(3):271–276. doi: 10.1038/s41372-022-01487-2

Figure 4.

Figure 4.

This bar graph shows the number subjects in the placebo and ondansetron-treated groups with a duration of hospitalization for each indicated time. It is noteworthy that the number of ondansetron-treated subjects with a duration of hospitalization that was less than ≤5 days or 6-10 days was increased but was decreased among those whose hospital stays was ≥16 days (vs. placebo).